Funding
This work was supported by a grant from Horizon 2020 (H2020-SMEInst-2016-2017) to a consortium led by Scandinavian Biopharma; by Scandinavian Biopharma; and by PATH (the United Kingdom’s Foreign and Commonwealth Development Office award 204139-101).